Wenqin Guo
- Nephrology top 10%
-
- Antiplatelet Therapy and Cardiovascular Diseases 5
- Atrial Fibrillation Management and Outcomes 5
- Heart Failure Treatment and Management 5
- Acute Myocardial Infarction Research 5
- Cardiovascular Function and Risk Factors 4
-
- Venous Thromboembolism Diagnosis and Management 4
-
- Diabetes Treatment and Management 5
-
- Coronary Interventions and Diagnostics 4
- Partner nations
- China
In The Last Decade
Wenqin Guo
23 papers receiving 305 citations
Peers
Comparison fields: 5 of 58
- Nephrology 60
- Cardiology and Cardiovascular Medicine 150
- Internal Medicine 20
- Endocrinology, Diabetes and Metabolism 74
- Virology 14
Countries citing papers authored by Wenqin Guo
This map shows the geographic impact of Wenqin Guo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wenqin Guo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wenqin Guo more than expected).
Fields of papers citing papers by Wenqin Guo
This network shows the impact of papers produced by Wenqin Guo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wenqin Guo. The network helps show where Wenqin Guo may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Wenqin Guo, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 20 | |
| 2 | 2023 | 7 | |
| 3 | 2022 | 11 | |
| 4 | 2022 | 2 | |
| 5 | 2021 | 2 | |
| 6 | 2021 | 49 | |
| 7 | 2021 | 10 | |
| 8 | 2021 | 8 | |
| 9 | 2021 | 9 | |
| 10 | 2021 | 20 | |
| 11 | 2020 | 15 | |
| 12 | 2019 | 28 | |
| 13 | 2018 | 4 | |
| 14 | 2018 | 4 | |
| 15 | 2017 | 19 | |
| 16 | 2017 | 14 | |
| 17 | 2017 | 7 | |
| 18 | 2016 | 12 | |
| 19 | 2016 | 22 | |
| 20 | Curative effect of shenwu guanxin granule preparation in treating senium congestive cardiac failure in 45 cases | 2007 | 1 |
About Wenqin Guo
Wenqin Guo is a scholar working on Internal Medicine, Cardiology and Cardiovascular Medicine and Endocrinology, Diabetes and Metabolism, having authored 23 papers that have together received 309 indexed citations. Recurring topics across this work include Antiplatelet Therapy and Cardiovascular Diseases (5 papers), Atrial Fibrillation Management and Outcomes (5 papers), Diabetes Treatment and Management (5 papers), Heart Failure Treatment and Management (5 papers), Acute Myocardial Infarction Research (5 papers), Cardiovascular Function and Risk Factors (4 papers), Coronary Interventions and Diagnostics (4 papers) and Venous Thromboembolism Diagnosis and Management (4 papers). The work is most often cited by research in Nephrology (60 citations), Cardiology and Cardiovascular Medicine (150 citations) and Internal Medicine (20 citations). Wenqin Guo has collaborated with scholars based in China. Frequent co-authors include Lang Li, Xiehui Chen, Hongbing Yan, Wenyu Guo, Weichao Huang, Ziliang Ye, Lang Li, Xiaoyuan Tian, Hongqing Li and Hanjun Zhao. Their work appears in journals such as PLoS ONE, Medicine and Frontiers in Pharmacology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.